Abstract
In some parts of the world, medicinal cannabinoids have already been used to treat nausea and vomiting associated with chemotherapy and wasting in diseases such as AIDS and terminal cancer. However, over the last several years, currently used cannabinoids, such as dronabinol, as well as newly developed cannabis-based medicines such as Sativex® (narrow ratio combination of Δ9-tetrahydrocannabinol and cannabidiol), have been investigated for the treatment of spasticity, chronic pain, disruption of sleep and urinary dysfunction associated with multiple sclerosis and other neurological disorders. Although some clinical trials have yielded positive results, others have not and there has been controversy regarding the use of subjective rating scales to measure pain and spasticity. Adverse side effects have been generally mild and transient; however, researchers and clinicians are still concerned about the prospect of long-term adverse side effects. This review will summarise and critically evaluate the currently available clinical trial data.
Keywords: Cannabinoids, cannabis, multiple sclerosis, pain, spasticity
Current Drug Therapy
Title: Will Medicinal Cannabinoids Prove to be Useful Clinically?
Volume: 2 Issue: 2
Author(s): Paul F. Smith
Affiliation:
Keywords: Cannabinoids, cannabis, multiple sclerosis, pain, spasticity
Abstract: In some parts of the world, medicinal cannabinoids have already been used to treat nausea and vomiting associated with chemotherapy and wasting in diseases such as AIDS and terminal cancer. However, over the last several years, currently used cannabinoids, such as dronabinol, as well as newly developed cannabis-based medicines such as Sativex® (narrow ratio combination of Δ9-tetrahydrocannabinol and cannabidiol), have been investigated for the treatment of spasticity, chronic pain, disruption of sleep and urinary dysfunction associated with multiple sclerosis and other neurological disorders. Although some clinical trials have yielded positive results, others have not and there has been controversy regarding the use of subjective rating scales to measure pain and spasticity. Adverse side effects have been generally mild and transient; however, researchers and clinicians are still concerned about the prospect of long-term adverse side effects. This review will summarise and critically evaluate the currently available clinical trial data.
Export Options
About this article
Cite this article as:
Smith F. Paul, Will Medicinal Cannabinoids Prove to be Useful Clinically?, Current Drug Therapy 2007; 2 (2) . https://dx.doi.org/10.2174/157488507780619059
DOI https://dx.doi.org/10.2174/157488507780619059 |
Print ISSN 1574-8855 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3903 |
Call for Papers in Thematic Issues
Novel Therapeutic Approaches and Biomarkers for Chronic Kidney Disease (CKD)
The thematic issue on "Novel Therapeutic Approaches and Biomarkers for CKD" aims to provide a comprehensive exploration of cutting-edge strategies for the management of chronic kidney disease (CKD). This issue will delve into emerging therapeutic targets, focusing on critical aspects such as podocyte injury, endothelial dysfunction, and tubulointerstitial fibrosis, which ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Seasonal and Perennial Allergic Conjunctivitis
Recent Patents on Inflammation & Allergy Drug Discovery Myocardial Energy Transport and Heart Failure
Current Cardiology Reviews Why Methylene Blue Have to Be Always Present in the Stocking of Emergency Antidotes
Current Drug Targets Evaluation of the Potential of Brazilian Red Propolis in the Acceleration of Healing in Surgical Wounds
The Natural Products Journal Preconditioning and Shear Stress in the Microcirculation in Ischemia-Reperfusion Injury
Current Cardiology Reviews Trends in the Pharmacology of Inflammatory and Allergic Eye Disorders
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Study on the Slow-Release Mometasone Furoate Injection of PLGA for the Treatment of Knee Arthritis
Current Drug Delivery Evaluation of Cell Tolerability of a Series of Lipoamino Acids Using Biological Membranes and a Biomembrane Model.
Current Drug Delivery Protective Effects of Anesthetics on Vascular Function Related to K<sup>+</sup> Channels
Current Pharmaceutical Design Cardiovascular Effects of Phosphodiesterase 5 Inhibitors
Current Pharmaceutical Design The Role of Chest High Resolution CT and RT-PCR in Diagnosis of Different Stages of Coronavirus (COVID-19) Pneumonia
New Emirates Medical Journal Adenosine Receptor Ligands in Clinical Trials
Current Topics in Medicinal Chemistry Prevention and Treatment of Coronary Distal Embolization in the Setting of Acute Myocardial Infarction: Pharmacologic Approach
Current Vascular Pharmacology Hypersensitivity Reactions to Ophthalmic Products
Current Pharmaceutical Design Endothelial Dysfunction, Oxidative Stress and Inflammation in Atherosclerosis: Beneficial Effects of Statins
Current Medicinal Chemistry Microvascular Function/Dysfunction Downstream a Coronary Stenosis
Current Pharmaceutical Design Cardiac SPECT-CT and PET-CT Imaging
Current Medical Imaging Clinical Applications of Transcranial Doppler Sonography
Reviews on Recent Clinical Trials Experimental Study of Therapeutic Efficacy of the Topical Preparation «Kourochitin» in Skin Allergy
Letters in Drug Design & Discovery Endothelial Function Assessment in Complicated Hypertension
Current Pharmaceutical Design